Stanford Medicine

The Sean N. Parker Center for Allergy and Asthma Research at Stanford University is a groundbreaking facility dedicated to improving treatments for both children and adults suffering from allergies and asthma. Its mission goes beyond just finding better solutions; it also focuses on understanding the immune system's role in these conditions and working towards a permanent cure.

National

English

Online/Digital

Outlet metrics

Domain Authority

Ranking

Global

N/A

Country

N/A

Articles

Blood test eases diagnosis of invasive mold disease

2 months ago | med.stanford.edu

Stanford Medicine is the first to offer the new blood test for mold infections deep inside the body, sparing patients from tissue biopsies.
Stanford infuses first patient with innovative solid tumor therapy | Stanford Cancer Institute

Jan 13, 2025 | med.stanford.edu

Stanford treated its first patient with Tecelra, a breakthrough engineered T cell receptor therapy that uses a patient’s own immune cells to target cancer.
Helen Blau awarded the National Medal of Science

Jan 12, 2025 | med.stanford.edu | Krista Conger

After completing a doctorate in biology at Harvard followed by a postdoctoral position at the University of California, San Francisco, Blau arrived at Stanford University in 1978 as an assistant professor of pharmacology in the School of Medicine - becoming one of the first women to be hired on the tenure track in the basic sciences. (The other was Carla Shatz, PhD, professor of biology and of neurobiology and the Sapp Family Provostial Professor.
Unique Stanford Medicine-designed AI predicts cancer prognoses, responses to treatment

Jan 8, 2025 | med.stanford.edu | Krista Conger

"The biggest unmet clinical need is for models that physicians can use to guide patient treatment," Li said. "Does this patient need this drug? Or should we instead focus on another type of therapy?
Researchers use AI to help predict and identify subtypes of Type 2 diabetes from simple glucose monitor

Jan 7, 2025 | med.stanford.edu | Hanae Armitage

The technology could have been useful for Snyder years ago when he learned he was prediabetic. "When I found out I was on my way to becoming diabetic, I increased my muscle mass, which is one of the common ways to help decrease sugar in the blood, but it had no effect. That's because I'm not traditionally insulin resistant," he said. His variety of Type 2 diabetes stems from something called a beta cell deficiency, which means that the cells that produce insulin don't function the way they should.
Treating brain cancer with immunotherapy | Stanford Cancer Institute

Jan 7, 2025 | med.stanford.edu

Reena Thomas explains why glioblastoma, and brain cancer, can be challenging to treat and what innovations may help improve patients’ quality of life.
AI may help researchers with medical chart review

Jan 6, 2025 | med.stanford.edu | Erin Digitale

The study used medical records from 1,201 children who were 6 to 11 years old, were patients at 11 pediatric primary care practices in the same health care network, and had a prescription for at least one ADHD medication. Such medications can have disruptive side effects, such as suppressing a child’s appetite, so it is important for doctors to inquire about side effects when patients are first using the drugs and adjust dosages as necessary.
Researchers at Stanford University and RAND awarded grant focused on addressing grief and substance use disorders among people bereaved by drug overdose deaths | Department of Psychiatry and Behavioral Sciences | Stanford Medicine

Dec 30, 2024 | med.stanford.edu
Stanford Medicine scientists design workaround that improves response to flu vaccine

Dec 19, 2024 | med.stanford.edu | Bruce Goldman

Stanford Medicine scientists have designed a way to make our seasonal influenza vaccinations more broadly effective and possibly to protect us from new flu variants with pandemic potential. In a study published online Dec. 19 in Science, they’ve shown in cultured human tonsil tissue that the method works. Flu season is upon us, and flu is no joke. Every year, the influenza virus kills hundreds of thousands of people and sends millions to the hospital.
Stanford scientists transform ubiquitous skin bacterium into a topical vaccine

Dec 11, 2024 | med.stanford.edu | Bruce Goldman

Imagine a world in which a vaccine is a cream you rub onto your skin instead of a needle a health care worker pushes into your one of your muscles. Even better, it's entirely pain-free and not followed by fever, swelling, redness or a sore arm. No standing in a long line to get it. Plus, it's cheap. Thanks to Stanford University researchers' domestication of a bacterial species that hangs out on the skin of close to everyone on Earth, that vision could become a reality.